Modular Medical Announces Participation at Upcoming Investor Conferences
Modular Medical Inc. (NASDAQ:MODD) has announced CEO Jeb Besser's participation in two upcoming investor conferences. The H.C. Wainwright 24th Annual Global Investment Conference will be held from September 12-14, 2022, in New York, with Mr. Besser's presentation available on September 12 at 7:00 a.m. ET. Additionally, he will engage in one-on-one meetings at the Lake Street Capital Markets 6th Annual Best Ideas Growth Conference on September 14. Modular Medical aims to innovate affordable insulin pump technology, making diabetes care accessible to a broader audience.
- None.
- None.
SAN DIEGO, CA / ACCESSWIRE / September 7, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of easy to use and affordable insulin pump technology, today announced that Jeb Besser, the Company's Chief Executive Officer, will be participating in the following investor conferences:
H.C. Wainwright 24th Annual Global Investment Conference, September 12 - September 14, 2022 at the Lotte New York Palace Hotel, New York, NY: Mr. Besser's corporate presentation will be available for viewing on September 12, 2022, beginning at 7:00 a.m. ET. An archived replay of the webcast will be available on the Company's investor relations website at https://modular-medical.com/events. Mr. Besser will also participate in one-on-one meetings at the conference. To schedule a one-on-one meeting, please contact your H.C. Wainwright representative.
Lake Street Capital Markets 6th Annual Best Ideas Growth Conference, September 14, 2022 at The Yale Club, New York, NY: Mr. Besser will host one-on-one meetings with investors throughout the day. To schedule a one-on-one meeting, please contact your Lake Street representative.
About Modular Medical, Inc.
Modular Medical, Inc. (NASDAQ:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding MODD, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
All trademarks mentioned herein are the property of their respective owners.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
View source version on accesswire.com:
https://www.accesswire.com/714931/Modular-Medical-Announces-Participation-at-Upcoming-Investor-Conferences
FAQ
What investor conferences is Modular Medical participating in?
When will Jeb Besser's presentation be available?
What is the focus of Modular Medical's technology?
Where can I find more information about Modular Medical?
How can I schedule a meeting with Modular Medical during the conferences?
